Molndal, Sweden · Founded 2018 · Privately Held (backing)
Developer of medical devices designed for the global antibiotic resistance crisis. Amferia is based in Molndal, Sweden and was founded in 2018. Its last reported valuation was $8.9 million in Sep 2024. It has raised $7.9 million.
Last reported valuation
$8.9M
Oct 2026
Priced at
—
Total raised
$7.9M
Last round
—
Cap table — not yet on record
Amferia's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Amferia with a free account
·Watch Amferia: the Monday email on marks, rounds and moves
